SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (464938)3/19/2009 12:56:28 PM
From: bentway  Respond to of 1574017
 
Big Pharma spends much more on advertising than on developing new drugs. Many of Big Pharma's "new" drugs are just combinations or the tiniest of tweaks to their old drugs going off-patent. It's more in Big Pharma's interest to develop lifetime maintenance drugs than any actual cures.

Bio-science promises actual cures. I'd like to see them put Big Pharma out of business. In the future, taking pills for your ills will be a primitive way to treat illness.



To: i-node who wrote (464938)3/19/2009 1:11:56 PM
From: Tenchusatsu  Respond to of 1574017
 
Inode, > Big Pharma, to some extent, isn't playing a "house" game -- they on the other side, rolling the dice.

They're also loading the dice and tweaking the payouts for maximum return.

In a way, they have to. The high risks are partly created by the public, who is increasingly adopting an entitlement mentality to health care. Cause you know, s--t is not supposed to happen anymore, and lawyers will make sure of that.

Tenchusatsu


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News